- 专利标题： Anti-lymphotoxin-beta receptor antibodies as anti-tumor agents
-
申请号： US09931402申请日： 2001-08-16
-
公开(公告)号： US07001598B2公开(公告)日： 2006-02-21
- 发明人: Jeffrey L. Browning , Werner Meier , Christopher D. Benjamin
- 申请人： Jeffrey L. Browning , Werner Meier , Christopher D. Benjamin
- 申请人地址： US MA Cambridge
- 专利权人： Biogen Idec MA Inc.
- 当前专利权人： Biogen Idec MA Inc.
- 当前专利权人地址： US MA Cambridge
- 代理机构： Lahive & Cockfield LLP
- 代理商 Amy E. Mandragouras; Cristin E. Howley
- 主分类号： A61K49/00
- IPC分类号： A61K49/00 ; A61K39/395
摘要：
This invention relates to compositions and methods useful for treating or reducing the advancement, severity or effects of neoplasia by the administration of at least two or more lymphotoxin beta receptor (LT-β receptor) activating agents where at least one LT-β receptor activating agent is an anti-LT-β receptor antibody.
公开/授权文献
信息查询
